STEXNasdaqSecurity & Commodity Brokers, Dealers, Exchanges & ServicesFiscal year ends December 31
Streamex Corp.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.37−0.00 (-0.80%)
Close on Oct 19, 2026
- Market cap
- $67.53M
- P/E (TTM)
- –
- Dividend yield
- –
Streamex Corp. revenue by segment
By business segment
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|
| Corporate Segment [Member] | – | $40.00K | $18.00K | $286.00K | $441.00K | $0 | – | – |
| Viral Clear [Member] | – | – | – | $0 | $0 | $0 | – | – |
| "NeuroClear Technologies, Inc (""NeuroClear"") [Member]" | – | – | – | $0 | $0 | $0 | – | – |
| ViralClear Pharmaceuticals, Inc. [Member] | – | – | $18.00K | – | – | – | – | – |
| Operating income | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | YoY |
|---|---|---|---|---|---|---|---|
| Corporate Segment [Member] | – | – | -$29.27M | -$26.59M | -$29.77M | – | – |
| Viral Clear [Member] | – | – | – | -$672.00K | -$3.63M | – | – |
| "NeuroClear Technologies, Inc (""NeuroClear"") [Member]" | – | – | – | -$3.00K | -$7.00K | – | – |
| BioSig AI Sciences, Inc. [Member] | – | – | -$745.00K | -$3.00K | – | – | – |
| ViralClear Pharmaceuticals, Inc. [Member] | – | – | $1.50M | -$672.00K | – | – | – |
By product or service
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|
| Service [Member] | – | – | $18.00K | $32.00K | $27.00K | $0 | – | – |
| Product [Member] | – | – | – | $254.00K | $414.00K | $0 | – | – |
By region
From the segment and revenue-disaggregation notes of Streamex's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.